Skip to content

K-Stock Briefing

https://kstockbriefing.com

  • About Us
  • Weekly News
  • IR Room
  • RESEARCH
    • Semiconductors
  • Disclosures
    • Semiconductors
    • Energy
    • Bio & Healthcare
    • Defense
    • Shipbuilding
    • Automotive
  • Toggle search form
  • [Disclosure] Celltrion (068270) – Treasury Share Acquisition Decision / 2025-04-03 Disclosures
  • [Disclosure] ISU PETASYS (007660) – Investor Relations (IR) Holding / 2025-11-14 Semiconductors
  • [Disclosure] KEPCO (015760 / KEP) – Submission of Audit Report / 2026-03-10 Disclosures
  • [Disclosure] Hanwha Systems (272210) – Decision on Cash and In-Kind Dividend / 2025-02-21 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Execution of Single Sales or Supply Contract / 2025-12-22 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Decision on Disposal of Treasury Shares / 2025-10-30 Disclosures
  • [Disclosure] SK hynix (000660 / SKHY) – Decision on Closure of Shareholders’ Register (Record Date) for Cash/In-Kind Dividend / 2025-07-23 Semiconductors
  • [Disclosure] HPSP (403870) – Resolution on Convening of Extraordinary General Meeting of Shareholders / 2024-07-18 Semiconductors

[Disclosure] SK hynix (000660 / SKHY) – Losses Incurred from Derivative Transactions / 2026-02-25

Posted on February 25, 2026August 11, 2026 By K-STOCK Editor

Fact Source: Financial Supervisory Service DART
Market: KOSPI (000660)

💡 3-Second Summary

SK hynix recognized an accounting-based cumulative derivative loss of KRW 8.366T (11.3% of equity) driven by stock price appreciation and exercise of exchange rights on previously issued exchangeable bonds (EBs).

📊 [Key Disclosure Content & Key Figures Summary]

  • Derivative Type & Loss Details
    • Type of Derivative: Exchangeable Bonds (EBs)
    • Amount of Loss Incurred: KRW 8,365,976,218,909 (KRW 8.366T)
    • Equity Base: KRW 73,915,703,612,985 (Based on consolidated financial statements as of FY2024 end)
    • Ratio to Equity: 11.3%
    • Large-scale Corporation: Applicable
  • Cause & Breakdown of Incurred Loss
    • 2025 Annual Cumulative Derivative Loss Breakdown (2025-01-01 ~ 2025-12-31):
      • Realized Derivative Transaction Loss: KRW 4,202,672,531,917
      • Unrealized Derivative Valuation Loss: KRW 4,163,303,686,992
      • Total Cumulative Loss: KRW 8,365,976,218,909
    • Key Cause: Accounting recognition of losses resulting from stock price increases and exchange rights execution regarding exchangeable bonds issued on April 11, 2023
  • Confirmation Date & Financial Impact
    • Date of Loss Confirmation: 2026-02-25 (Board resolution date following external auditor review of FY2025 consolidated financials)
    • Actual Financial Impact: Non-cash accounting loss resulting from fair value evaluation of embedded derivatives under K-IFRS with zero cash outflow. The loss is offset against gains on disposal of treasury stock upon bond-to-stock exchange, presenting a minimal impact on total equity.

📝 Editor’s Comment (Key Follow-up Checkpoint)

📌 Non-Cash Derivative Loss Accounting and Total Equity Impact

This disclosure reflects non-cash book losses arising from fair value revaluation of embedded derivatives in exchangeable bonds due to stock price movements. Verifying how these valuation losses are offset against gains from treasury stock disposal and confirming their minimal net impact on total equity is crucial for evaluating SK hynix’s actual financial standing and net asset stability. Final verified figures and detailed breakdowns can be cross-referenced in the upcoming Annual Report and Audit Report under the footnotes for Derivative Instruments and Financial Liabilities.

📢 Disclaimer & Source Notice

Source: This content was newly structured and generated based on official disclosure data from the Financial Supervisory Service’s DART system.

Investment Risk Warning: This material is provided for informational and language reference purposes only. Under no circumstances does it constitute financial advice or a recommendation to buy or sell specific stocks. All investment decisions and financial responsibilities rest solely with the investor.

Contact: For compliance inquiries or copyright requests, please contact ksb220805@gmail.com.

Search by
Company Name or Stock Ticker.
Semiconductors, Disclosures

Post navigation

Previous Post: [Disclosure] SK hynix (000660 / SKHY) – Decision on New Facility Investment / 2026-02-25
Next Post: [Disclosure] Samsung Electronics (005930) – (Correction) Resolution on Convening of General Meeting of Shareholders / 2026-02-25

Related Posts

  • [Disclosure] ISU PETASYS (007660) – Report on Reasons for Holding Annual General Meeting on Concentrated Date / 2024-03-14 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Advance Notice of Financial Results Disclosure / 2024-04-17 Disclosures
  • [Disclosure] Hanwha Systems (272210) – Setting of Record Date for Shareholders / 2024-12-12 Disclosures
  • [Disclosure] Hanwha Systems (272210) – Decision on Paid-in Capital Increase / 2025-11-24 Disclosures
  • [Disclosure] Hanwha Aerospace (012450) – Submission of Audit Report / 2025-03-17 Disclosures
  • [Disclosure] KEPCO (015760 / KEP) – Financial Results Disclosure Schedule Announcement / 2026-02-23 Disclosures
  • [Disclosure] Hyundai Motor (005380) – Investor Relations (IR) Holding / 2024-04-18 Disclosures
  • [Disclosure] Hanmi Semiconductor (042700) – Outlook on Operating Performance (Consolidated K-IFRS Fair Disclosure) / 2024-07-08 Semiconductors
  • [Disclosure] Samsung Electronics (005930) – Decision on Disposal of Treasury Stock / 2026-07-13 Disclosures
  • [Disclosure] Daeduck Electronics (353200) – Investor Relations (IR) Holding (Information Disclosure) / 2025-04-17 Semiconductors
  • [Disclosure] Hyundai Motor (005380) – Reference Price for Interim (Quarterly) Ex-Dividend (Hyundai Motor Preferred) / 2026-05-27 Disclosures
  • [Disclosure] KEPCO (015760 / KEP) – Change in Revenue or Profit/Loss Structure Notice / 2026-02-26 Disclosures
  • [Disclosure] Hanwha Ocean (042660) – Sales and Supply Contract / 2025-11-24 Disclosures
  • [Disclosure] Samsung Biologics (207940) – Major Management Matters (Correction) / 2024-08-29 Disclosures

Copyright © 2026 K-Stock Briefing.

Powered by PressBook News Dark theme